37 results
Page 2 of 2
424B2
j12put49ucpz6q
24 Jan 20
Prospectus for primary offering
7:24am
424B5
3xouevbvu331t9z
21 Jan 20
Prospectus supplement for primary offering
5:31pm
20-F/A
EX-10.15
p9dsct
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
uprgvf
26 Jun 19
Annual report (foreign) (amended)
6:07am
6-K
EX-99.1
1naqpn a0tqspzbw4qj
11 Jun 19
Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China
7:00am
6-K
snnonn1vkiz1
12 Oct 18
Current report (foreign)
7:30am
424B4
3p0fp likztw9
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
EX-4.17
1snn9p mce5
30 Apr 18
Annual report (foreign)
9:07am
20-F
ofisg56qfyepnxi
30 Apr 18
Annual report (foreign)
9:07am
20-F
EX-4.11
tztv0jsdmbq6k8fzin
30 Apr 18
Annual report (foreign)
9:07am
20-F
EX-4.15
jdtvw2sjhd
30 Apr 18
Annual report (foreign)
9:07am